ALAMEDA, Calif.--(BUSINESS WIRE)--Aug. 25, 2006--Advanced Cell Technology, Inc. (OTCBB:ACTC), developers of groundbreaking human embryonic stem cell technologies to create next-generation medical therapies, will host a live investor conference call with a simultaneous webcast, today at 12 noon Eastern, to discuss its novel technique to generate human embryonic stem cell lines while preserving the original embryo’s potential for life and development.
